论文部分内容阅读
作者观察噻吗心安治疗8例特殊类型青光眼的疗效,随诊6个月以上,包括无晶体性青光眼、新生血管性青光眼、剥脱性青光眼、色素性青光眼和青年性青光眼。噻吗心安浓度为0.1%、0.25%或0.5%,每日点眼3次。每日测眼压,比较滴药前后视力、瞳孔大小、视野、血压、裂隙灯和眼底镜检查结果。研究表明,噻吗心安对这些特殊类型的青光眼为一有效药物,可降低眼压约20%,在6个月的观察期间一直保持眼压降低的疗效。所有的患者几乎均能耐受该药,仅一例患者因严重气喘而停用。患者年龄为30—73岁,未点噻吗心安之前,有以抗青光眼手术加缩瞳剂治疗者,有单用缩瞳剂治疗者,但眼压控制均不满意。有的还须口服醋氮酰胺,停药眼压即回升。接受噻吗心安治疗后,6例患者仅单独使用噻吗心安眼压即明显下降至正常水平,2例分别与毛果芸香碱和cata
The authors observed the efficacy of timolol in the treatment of 8 cases of special type of glaucoma, followed up for 6 months or more, including aphakic glaucoma, neovascular glaucoma, exfoliative glaucoma, pigmented glaucoma and young glaucoma. Timolol concentration of 0.1%, 0.25% or 0.5%, eye drops 3 times a day. Intraocular pressure was measured daily, before and after comparing drops of vision, pupil size, visual field, blood pressure, slit lamp and ophthalmoscopy results. Studies have shown that timolol on these special types of glaucoma as a valid drug, can reduce the intraocular pressure about 20%, 6 months of observation has been maintained during the efficacy of reduced intraocular pressure. Almost all patients tolerated the drug, with only one patient discontinued due to severe asthma. Patient age was 30-73 years old, did not point timolol before anti-glaucoma surgery and miosis agent treatment, there is a single miotic agent treatment, but intraocular pressure control are not satisfied. Some also have to oral etoposide, withdrawal intraocular pressure that is recovered. After receiving timolol treatment, 6 patients only timolol intraocular pressure that significantly decreased to normal levels, 2 cases were with pilocarpine and cata